COVID-19 and Vaccine Safety Brings Pharmacovigilance Center Stage
The public is more aware of drug safety and health ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
The public is more aware of drug safety and health ...
DCTs completely revise historical trial processes by executing trials through ...
Managing the submission of medicinal products, medical devices, and biologics ...
Data is the lifeblood of businesses today. Data informs strategy ...
Change is the lone constant you can depend on. When ...
When selecting an IDMP solution, remember decisions made today will ...
Why Having a Well-Prepared eTMF is Important A well-prepared Electronic ...
LIFESPHERE®Among the Best eTMF Systems in the Market Key eTMF ...
Your team’s workload grows by the day. The volume of Safety cases you’re ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved